PMID: 8599764Apr 1, 1996Paper

Structure of human beta-glucuronidase reveals candidate lysosomal targeting and active-site motifs

Nature Structural Biology
S JainJ H Grubb

Abstract

The X-ray structure of the homotetrameric lysosomal acid hydrolase, human beta-glucuronidase (332,000 Mr), has been determined at 2.6 A resolution. The tetramer has approximate dihedral symmetry and each promoter consists of three structural domains with topologies similar to a jelly roll barrel, an immunoglobulin constant domain and a TIM barrel respectively. Residues 179-204 form a beta-hairpin motif similar to the putative lysosomal targeting motif of cathepsin D, supporting the view that lysosomal targeting has a structural basis. The active site of the enzyme is formed from a large cleft at the interface of two monomers. Residues Glu 451 and Glu 540 are proposed to be important for catalysis. The structure establishes a framework for understanding mutations that lead to the human genetic disease mucopolysaccharidosis VII, and for using the enzyme in anti-cancer therapy.

References

May 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·A KaplanW S Sly
Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M R NatowiczW S Sly
Dec 1, 1990·Archives of Biochemistry and Biophysics·M Ring, R E Huber
Jan 1, 1988·Annual Review of Immunology·P M AlzariR J Poljak
Jan 1, 1989·Progress in Nucleic Acid Research and Molecular Biology·K Paigen
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A OshimaR A Gravel
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R A JeffersonD Hirsh
Jan 1, 1985·Methods in Enzymology·K D Watenpaugh
Dec 19, 1972·Biochemistry·K D Hardman, C F Ainsworth
Mar 1, 1966·Annals of the Rheumatic Diseases·J C Caygill, D A Pitkeathly
Nov 1, 1966·Scientific American·D C Phillips
Jan 11, 1984·Nucleic Acids Research·J DevereuxO Smithies
Jun 30, 1994·Nature·R H JacobsonB W Matthews
Mar 1, 1994·Biological & Pharmaceutical Bulletin·D H KimK Kobashi
Aug 1, 1993·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·X LinJ Tang
Sep 5, 1993·Journal of Molecular Biology·W B DrendelS Jain
Jan 1, 1993·Advances in Cancer Research·M J Boyer, I F Tannock

❮ Previous
Next ❯

Citations

Nov 5, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Christiane Kunert-KeilHeyo K Kroemer
Jun 11, 2002·Journal of Molecular Biology·Paul C SmithJohn F Hunt
Sep 16, 2003·Journal of Molecular Biology·Lori A RoweIchiro Matsumura
Nov 5, 1997·Current Opinion in Structural Biology·B Henrissat, G Davies
Apr 26, 2003·Bioorganic & Medicinal Chemistry·Frédéric Schmidt, Claude Monneret
May 3, 2011·The Journal of Biological Chemistry·Tomoaki MatsuuraTetsuya Yomo
Dec 23, 2008·The Journal of Biological Chemistry·Ramon Hurtado-GuerreroDaan M F van Aalten
Jun 20, 2013·Rejuvenation Research·Huma NazImtaiyaz Hassan
Jun 14, 2012·Protein Engineering, Design & Selection : PEDS·Cheng-Pao ChenSteve R Roffler
Jan 28, 2009·Acta Crystallographica. Section D, Biological Crystallography·Thomas Lütteke
Mar 9, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Yasumitsu SakamotoKazuo T Nakamura
Nov 6, 2010·Science·Bret D WallaceMatthew R Redinbo
Jul 6, 2010·Applied and Environmental Microbiology·Sébastien PototGhislain Schyns
Aug 8, 2008·Bioinformation·Loganathan ArulPonnusamy Balasubramanian
Jan 1, 2008·Bioinformation·Loganathan ArulPonnusamy Balasubramanian
Oct 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Shunji TomatsuWilliam S Sly
Apr 29, 2014·Journal of Computer-aided Molecular Design·Khalid M KhanMohammad Iqbal Choudhary
Jan 9, 2016·Critical Reviews in Biotechnology·Prakram Singh Chauhan, Naveen Gupta
Mar 1, 2012·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Umme Afsari ZahuraTakao Ojima
Aug 25, 2015·Journal of Medical Microbiology·Ismail Hakki EkinOzgul Gulaydin
Dec 5, 2006·Molecular Microbiology·David Gordon LongstaffJoseph Adrian Krzycki
Nov 18, 2000·Structure·Z Marković-HousleyT Schirmer
Jan 16, 2007·Structure·Matthew Bashton, Cyrus Chothia
Jun 5, 2001·Protein Expression and Purification·S AichR Chen
Jun 22, 2016·Applied Microbiology and Biotechnology·Xudong FengChun Li
Oct 25, 2016·Journal of Computational Chemistry·Alex DicksonJohn Karanicolas
May 16, 2017·Bioorganic Chemistry·Mohd Syukri BaharudinMuhammad Ali
Apr 9, 2017·The Journal of Biological Chemistry·Samuel J Pellock, Matthew R Redinbo
Jan 29, 2002·Journal of Molecular Biology·Matthew Bashton, Cyrus Chothia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.